Pramlintide (Symlin) is a relatively new adjunct for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. Pramlintide is delivered as an acetate salt.
Read more about Pramlintide: Pharmacology, Approval, Design and Structure
Pramlintide (Symlin) is a relatively new adjunct for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. Pramlintide is delivered as an acetate salt.
Read more about Pramlintide: Pharmacology, Approval, Design and Structure